Johnson & Johnson
Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%
Johnson & Johnson Abiomed (Impella heart pumps) sub-franchise by Year
Abiomed (Impella heart pumps) sub-franchise — Worldwide reported growth YoY (%) (%)
Johnson & Johnson Abiomed (Impella heart pumps) sub-franchise: 17.1% in FY2025, up 2.6 pts from a year earlier.
Where the FY2025 figure comes from
“|| WW | 1,751 | 1,496 | 17.1 | 16.2 | 0.9”
Source: Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Reported in Form 8-K EX-99.2 Segment Sales Schedule.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Abiomed (Impella heart pumps) sub-franchise — Worldwide reported growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 28, 2025 | 17.1% | +2.6 pts | Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗ |
| FY2024 | Dec 29, 2024 | 14.5% | +7.4 pts | Form 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗ |
| FY2023 | Dec 31, 2023 | 7.1% | – | Form 8-K (a2023q4exhibit991.htm, filed 2024-01-23) ↗ |
Cite this data
StockData. (2026). Johnson & Johnson Abiomed (Impella heart pumps) sub-franchise (%), annual FY2023–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/mt-abiomed-rep-yoy
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.